My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 324

    1.

    Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy.

    Anderson JS, Bandi S, Kaufman DS, Akkina R.

    Retrovirology. 2006 Apr 19;3:24.PMID: 16623949 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.

    Anderson J, Akkina R.

    Retrovirology. 2005 Aug 18;2:53.PMID: 16109172 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.

    Bai J, Banda N, Lee NS, Rossi J, Akkina R.

    Mol Ther. 2002 Dec;6(6):770-82.PMID: 12498773 [PubMed - indexed for MEDLINE]Related articles

    5.

    TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages.

    Anderson J, Akkina R.

    Mol Ther. 2005 Oct;12(4):687-96.PMID: 16081321 [PubMed - indexed for MEDLINE]Related articles

    6.

    Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.

    Bai J, Gorantla S, Banda N, Cagnon L, Rossi J, Akkina R.

    Mol Ther. 2000 Mar;1(3):244-54.PMID: 10933940 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.

    Banerjea A, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R.

    Mol Ther. 2003 Jul;8(1):62-71.PMID: 12842429 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intracellular immunization of rhesus CD34+ hematopoietic progenitor cells with a hairpin ribozyme protects T cells and macrophages from simian immunodeficiency virus infection.

    Rosenzweig M, Marks DF, Hempel D, Heusch M, Kraus G, Wong-Staal F, Johnson RP.

    Blood. 1997 Dec 15;90(12):4822-31.PMID: 9389699 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.

    Bai J, Rossi J, Akkina R.

    AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):385-99.PMID: 11282007 [PubMed - indexed for MEDLINE]Related articles

    10.

    Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.

    Anderson J, Akkina R.

    Gene Ther. 2007 Sep;14(17):1287-97. Epub 2007 Jun 28.PMID: 17597795 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny.

    Dimitrova DI, Yang X, Reichenbach NL, Karakasidis S, Sutton RE, Henderson EE, Rogers TJ, Suhadolnik RJ.

    J Interferon Cytokine Res. 2005 Jun;25(6):345-60.PMID: 15957958 [PubMed - indexed for MEDLINE]Related articles

    13.

    Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection.

    Rosenzweig M, Marks DF, Hempel D, Lisziewicz J, Johnson RP.

    J Virol. 1997 Apr;71(4):2740-6.PMID: 9060627 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals.

    Gervaix A, Schwarz L, Law P, Ho AD, Looney D, Lane T, Wong-Staal F.

    Hum Gene Ther. 1997 Dec 10;8(18):2229-38.PMID: 9449376 [PubMed - indexed for MEDLINE]Related articles

    15.

    Suitability of bone marrow from HIV-1-infected donors for retrovirus-mediated gene transfer.

    Kearns K, Bahner I, Bauer G, Wei SF, Valdez P, Wheeler S, Woods L, Miller R, Casciato D, Galpin J, Church J, Kohn DB.

    Hum Gene Ther. 1997 Feb 10;8(3):301-11.PMID: 9048197 [PubMed - indexed for MEDLINE]Related articles

    16.

    Human immunodeficiency virus infection of human placental cord blood CD34+AC133+ stem cells and their progeny.

    Hariharan D, Li Y, Campbell DE, Douglas SD, Starr SE, Ho W.

    AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1545-52.PMID: 10580405 [PubMed - indexed for MEDLINE]Related articles

    17.

    T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.

    Ruiz M, Roodman ST, Bouhasin JD, Knutsen AP.

    Stem Cells. 1996 Jan;14(1):132-45.PMID: 8820959 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    In vitro T lymphopoiesis: a model system for stem cell gene therapy for AIDS.

    Rosenzweig M, Marks DF, Hempel D, Johnson RP.

    J Med Primatol. 1996 Jun;25(3):192-200.PMID: 8892040 [PubMed - indexed for MEDLINE]Related articles

    19.

    Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.

    Braun SE, Wong FE, Connole M, Qiu G, Lee L, Gillis J, Lu X, Humeau L, Slepushkin V, Binder GK, Dropulic B, Johnson RP.

    Mol Ther. 2005 Dec;12(6):1157-67. Epub 2005 Sep 15.PMID: 16168713 [PubMed - indexed for MEDLINE]Related articles

    20.

    siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.

    Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J.

    Anticancer Res. 2003 May-Jun;23(3A):1997-2005. Review.PMID: 12894572 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk